UNSPSC 51192317: Dextrose/Sodium chloride

Dextrose and Sodium Chloride Injection, USP (dextrose and sodium chloride inj) is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment and caloric supply in single dose containers for intravenous administration. It contains no antimicrobial agents.

UNSPSC 51192317 Dextrose/Sodium chloride is a Commodity code that state and local governments procure as pharmaceutical and medical supply components, though recent opportunities under this specific code show limited direct solicitation activity. The code appears in state and local purchasing systems primarily as a line-item component within broader emergency medical services, pharmacy, and clinical supply procurements. Recent solicitations naming dextrose/sodium chloride or closely related intravenous solutions and electrolyte products appear embedded in larger BLS/ALS pharmaceutical and supply contracts, such as the City of Tucson Fire Department's June 2026 RFP for comprehensive BLS and ALS pharmaceuticals, supplies, and vending systems, and Seminole County's June 2026 IFB for naloxone and drug deactivation systems. These broader procurements typically flow through fire departments, emergency medical services divisions, county health systems, and regional emergency response agencies.

Issuing bodies pursuing medical supply contracts that include dextrose/sodium chloride solutions span fire departments, county emergency services, and health system procurement offices across multiple states. The most active recent solicitations appear in Florida (Seminole County, Orange County) and Arizona (City of Tucson), with additional activity signaled through multistate cooperative purchasing arrangements such as MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products available to state and local facilities in Minnesota, Oregon, and other participating jurisdictions. The Tucson and Seminole County solicitations emphasize quarterly and as-needed delivery of emergency pharmaceuticals and supplies to centralized distribution points and field stations, with strict compliance requirements including FDA/DEA licensure, inventory management integration, and performance guarantees on fill rates and product expiration dating. MMCAP's cooperative vehicle demonstrates how state procurement offices and multistate alliances structure standing supply agreements for pharmaceutical items across distributed networks of local agencies. Direct commodity-level solicitations specifically for dextrose/sodium chloride solutions are less common than bundled emergency pharmaceutical RFPs; most state and local procurement activity bundles intravenous solutions with broader medication and supply categories under BLS/ALS or general pharmacy frameworks.